IPCA-AMITRIPTYLINE amitriptyline hydrochloride 25mg tablet bottle pack

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

amitriptyline hydrochloride, Quantity: 25 mg

Disponible desde:

Ipca Pharma (Australia) Pty Ltd

Designación común internacional (DCI):

amitriptyline hydrochloride

formulario farmacéutico:

Tablet

Composición:

Excipient Ingredients: hypromellose; magnesium stearate; microcrystalline cellulose; purified talc; colloidal anhydrous silica; crospovidone; lactose monohydrate; quinoline yellow aluminium lake; titanium dioxide; macrogol 6000; maize starch

Vía de administración:

Oral

Unidades en paquete:

100

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

For the treatment of major depression. Amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,Nocturnal enuresis where organic pathology has been excluded.

Resumen del producto:

Visual Identification: Yellow colour, circular, biconvex, film coated tablets with 'IA' over '25' debossed on one side and plain on the other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 12 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estado de Autorización:

Licence status A

Fecha de autorización:

2014-08-22